Pharma major Lupin targets $1 bn revenue from inorganic growth by FY18 #acceleron #pharma

Posted On May 15 2017 by

#lupin pharma # Pharma major Lupin targets $1 bn revenue from inorganic growth by FY18 Sohini Das | Ahmedabad Jan 19, 2016 10:01 AM IST Looking to add $1 billion in revenues from inorganic growth to reach its target turnover of $5 billion by 2018, pharma giant Lupin, which is currently worth $2 billion, says it is open to late stage speciality assets. Lupin s chief financial officer Ramesh Swaminathan told Business Standard that while $200-300 million per acquisition is a sweet spot for the company historically, it does not mean that the company won t look at bigger acquisitions. …


India – s Pharmaceutical industry is on a good growth path, but will have to watch out for the regulatory interventions #pharmaceutical #industry

Posted On May 14 2017 by

#future of pharmaceutical industry # India’s Pharmaceutical industry is on a good growth path, but will have to watch out for the regulatory interventions The Indian pharma industry is on a good growth path and is likely to be in the top 10 global markets in value term by 2020. according to the PwC – CII report titled “India Pharma Inc: Gearing up for the next level of growth”. High burden of disease, good economic growth leading to higher disposable incomes, improvements in healthcare infrastructure and improved healthcare financing are driving growth in the domestic market, the report highlighted. The …


Strong Growth Ahead for Contract Manufacturing #pharmajob

Posted On May 3 2017 by

#pharmaceutical contract manufacturer # Pharma Manufacturing Strong Growth Ahead for Contract Manufacturing Contract manufacturing organizations (CMOs) of small- and large-molecule drug substances and formulated drug products have had profitable businesses in recent years, including 2015. Growth rates for contract manufacturing have been much higher than that of the market for the pharmaceutical/biopharmaceutical industry due to several factors: • Increasing consumption of medicines around the world, both in emerging markets as incomes rise and mature markets due to aging of the population; • A more robust pipeline of drug candidates and an increasing rate of FDA NDA/BLA approvals; • The growing …


SteriPack Drives Pharmaceutical Packaging Growth – Blister Packaging #pharma #times

Posted On Apr 21 2017 by

#pharmaceutical packaging companies # PL + 48 71381 8199 MY + 60 33167 3596 US + 1 863 648 2333 SteriPack Malaysia Drives Pharmaceutical Packaging Growth SteriPack s facility in Malaysia ensures that the group can offer state of the art blister packaging services all over the globe. SteriPack is a worldwide packaging solutions provider, serving the medical device and pharmaceutical industries. Since its foundation in 1994, the company has invested significantly by building its processes and quality systems to extremely high standards throughout its facilities located in Ireland, Poland, Malaysia, and the US. In recent times, SteriPack s facility …


Strong Growth Ahead for Contract Manufacturing #pharma #market #research

Posted On Apr 15 2017 by

#pharmaceutical contract manufacturer # Pharma Manufacturing Strong Growth Ahead for Contract Manufacturing Contract manufacturing organizations (CMOs) of small- and large-molecule drug substances and formulated drug products have had profitable businesses in recent years, including 2015. Growth rates for contract manufacturing have been much higher than that of the market for the pharmaceutical/biopharmaceutical industry due to several factors: • Increasing consumption of medicines around the world, both in emerging markets as incomes rise and mature markets due to aging of the population; • A more robust pipeline of drug candidates and an increasing rate of FDA NDA/BLA approvals; • The growing …


SteriPack Drives Pharmaceutical Packaging Growth – Blister Packaging #avalon #pharma

Posted On Apr 11 2017 by

#pharmaceutical packaging companies # PL + 48 71381 8199 MY + 60 33167 3596 US + 1 863 648 2333 SteriPack Malaysia Drives Pharmaceutical Packaging Growth SteriPack s facility in Malaysia ensures that the group can offer state of the art blister packaging services all over the globe. SteriPack is a worldwide packaging solutions provider, serving the medical device and pharmaceutical industries. Since its foundation in 1994, the company has invested significantly by building its processes and quality systems to extremely high standards throughout its facilities located in Ireland, Poland, Malaysia, and the US. In recent times, SteriPack s facility …


Pharmaceutical Industry Trends, Analysis, Statistics – Market Growth #pharma #events

Posted On Apr 10 2017 by

#pharmaceutical industry growth # Pharmaceutical Industry Analysis: Latest Market Research Reports Topics under Pharmaceutical Global Pharmaceutical Industry Overview The pharmaceutical industry consists of companies involved in the research, development and marketing of drugs and biologics. The pharmaceutical market was valued at $1 trillion in 2013, according to IMS. The market grew at a 4% compound annual growth rate (CAGR) from 2009 to 2013. It grew well in 2010 and 2011 before a decline in growth in 2012 and 2013. The pharmaceutical market was driven by a rise in healthcare spending and high growth in both emerging markets and the biologics …


India – s Pharmaceutical industry is on a good growth path, but will have to watch out for the regulatory interventions #pharma #suppliers

Posted On Apr 9 2017 by

#future of pharmaceutical industry # India’s Pharmaceutical industry is on a good growth path, but will have to watch out for the regulatory interventions The Indian pharma industry is on a good growth path and is likely to be in the top 10 global markets in value term by 2020. according to the PwC – CII report titled “India Pharma Inc: Gearing up for the next level of growth”. High burden of disease, good economic growth leading to higher disposable incomes, improvements in healthcare infrastructure and improved healthcare financing are driving growth in the domestic market, the report highlighted. The …


SteriPack Drives Pharmaceutical Packaging Growth – Blister Packaging #valeo #pharma

Posted On Apr 2 2017 by

#pharmaceutical packaging companies # PL + 48 71381 8199 MY + 60 33167 3596 US + 1 863 648 2333 SteriPack Malaysia Drives Pharmaceutical Packaging Growth SteriPack s facility in Malaysia ensures that the group can offer state of the art blister packaging services all over the globe. SteriPack is a worldwide packaging solutions provider, serving the medical device and pharmaceutical industries. Since its foundation in 1994, the company has invested significantly by building its processes and quality systems to extremely high standards throughout its facilities located in Ireland, Poland, Malaysia, and the US. In recent times, SteriPack s facility …


India – s Pharmaceutical industry is on a good growth path, but will have to watch out for the regulatory interventions #pharma #co

Posted On Mar 30 2017 by

#future of pharmaceutical industry # India’s Pharmaceutical industry is on a good growth path, but will have to watch out for the regulatory interventions The Indian pharma industry is on a good growth path and is likely to be in the top 10 global markets in value term by 2020. according to the PwC – CII report titled “India Pharma Inc: Gearing up for the next level of growth”. High burden of disease, good economic growth leading to higher disposable incomes, improvements in healthcare infrastructure and improved healthcare financing are driving growth in the domestic market, the report highlighted. The …